Browse grants

Department of Pesticide Regulation · $100K–$1M

California's Department of Pesticide Regulation (DPR) 2027 Sustainable Pest Management Grants Program is open to a broad range of applicants, including nonprofits, businesses, individuals, universities, and government and tribal agencies. It funds projects that advance integrated pest management practices, such as alternatives to weed, rodent, and fumigant use, through research, outreach, and implementation in agricultural, urban, or wildland settings, with award budgets ranging from $100,000 to $1,000,000. Principal investigators may submit at most two proposals per year, and all applicants must meet DPR's specific eligibility requirements outlined in the official solicitation. Applications are due by September 2, 2026.

National Institutes of Health · Amount varies

This NIH R36 award funds up to two years of doctoral dissertation research on substance use and substance use disorders, aligned with NIDA funding priorities, aimed at doctoral candidates across academic disciplines. Eligible U.S. institutions include HBCUs, tribal colleges, and minority-serving institutions; foreign organizations are not eligible. The deadline is September 7, 2026.

National Institutes of Health · Amount varies

This NIH/National Cancer Institute R01 award supports assay development and screening to discover small-molecule chemical probes, drugs, or immunomodulators, with no clinical trials allowed. It is aimed at research institutions and investigators conducting early-stage discovery research, and lists a broad set of eligible U.S. organization types. Funding amounts are not specified here. Applications are submitted through eligible organizations.

National Institutes of Health · Up to $499K

This NIH/National Cancer Institute R01 award funds projects to improve the reliability and translational usefulness of mammalian cancer and tumor models, with no clinical trials allowed. It is aimed at research institutions and investigators, with a broad list of eligible U.S. organization types. The stated maximum award is about $499,000. Applications are submitted through eligible organizations rather than by individuals.

National Institutes of Health · Amount varies

This NIH P50 SPORE grant funds translational cancer research centers focused on improving prevention, early detection, diagnosis, and treatment for a specific organ system or related group of cancers. Projects must have a clear path toward a translational human endpoint within the grant period, and it's aimed at eligible U.S. research institutions. The deadline is September 25, 2026.

National Institutes of Health · Up to $400K

This NIH R25 grant (up to $400,000) funds institutional programs that engage grades 6-12 and undergraduate students, and their teachers or faculty, in hands-on cancer research experiences to build interest in biomedical research careers. It's aimed at eligible U.S. institutions; foreign organizations are not eligible. The deadline is September 28, 2026.

National Institutes of Health · Amount varies

This NIH BRAIN Initiative program (UG3/UH3) is a milestone-driven cooperative agreement supporting translational development and small clinical studies of next-generation therapeutic and diagnostic devices for nervous and neuromuscular disorders. Eligible applicants are institutions, including minority-serving institutions, HBCUs, and tribal colleges; foreign organizations and foreign components of U.S. organizations are not eligible to apply, though foreign components are otherwise allowed. NIH program staff participate in project planning and monitoring. No award amount is stated; eligibility centers on research institutions able to develop and test devices.

National Institutes of Health · Amount varies

This NIH BRAIN Initiative program (UH3) funds small clinical trials to advance next-generation devices for recording and modulating the human central nervous system. Eligible applicants are institutions, including minority-serving institutions, HBCUs, and tribal colleges; foreign organizations and foreign components of U.S. organizations are not eligible to apply, though foreign components are otherwise allowed. No award amount is stated. This is a clinical-research mechanism aimed at research institutions capable of conducting device trials.

DOC NOAA - ERA Production · Amount varies

This NOAA Broad Agency Announcement for the Office of Education seeks applications for special projects tied to NOAA's strategic and mission goals, including education and environmental work. Eligibility is broad: higher-education institutions, nonprofits, commercial organizations, international or foreign organizations and governments, individuals, and state, local, and tribal governments may apply, subject to the statutory authority for the specific activity. Federal organizations cannot be funded. No specific award amount is stated; contact program officials and submit to the appropriate line-office BAA.

Governor’s Office of Land Use and Climate Innovation · $750K–$4.5M

Nonprofits, public agencies, tribal governments, community-based organizations, and public higher education institutions in California can apply, but only as part of a coalition — every application needs a Lead Applicant plus at least one Co-Applicant. It funds heat-related infrastructure planning and demonstration projects ($750,000–$1.2 million) or implementation of already-planned heat infrastructure ($3 million–$4.5 million). At least 40% of funding is reserved for projects benefiting Disadvantaged Communities, with 10% of that share going to Severely Disadvantaged Communities. Applicants must first submit a Pre-Application Interest Form via Submittable (window closes July 21 or August 11, 2026) before the Full Application is due October 13, 2026.

National Institutes of Health · Amount varies

This NIH (NCI) UH2/UH3 award funds both analytical and clinical validation of molecular, cellular, or imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, and treatment response. Eligible applicants include higher-education institutions, nonprofits, tribal governments, and federal agencies; clinical trials are not allowed and applicants should already have assays that work on human samples. Foreign organizations and the foreign components of U.S. organizations are not eligible to apply, though some foreign components are allowed. No specific award amount is stated in this record.

National Institutes of Health · Up to $250K

This NIH (NCI) UH3 award funds the clinical validation of already analytically validated molecular, cellular, or imaging biomarker assays for cancer detection, diagnosis, prognosis, monitoring, and treatment response, using specimens from clinical trials or studies. Eligible applicants include higher-education institutions, nonprofits, tribal governments, and federal agencies; clinical trials are not allowed and early-stage technology development is out of scope. Applicants must already have an analytically validated assay, which narrows who can realistically apply. Foreign organizations and foreign components of U.S. organizations are not eligible to apply; stated funding is around $250,000.

National Institutes of Health · Amount varies

This NIH (NCI) award funds revision applications to clinically validate biomarker assays that were originally developed through existing NIH-supported research grants, meaning applicants generally need an active or prior NCI-supported assay to revise. Eligible applicants include higher-education institutions, nonprofits, tribal governments, and federal agencies; clinical trials are not allowed and early-stage technology development is out of scope. Because it builds on prior NIH funding, eligibility is effectively narrow. No specific award amount is stated in this record.

National Institutes of Health · Amount varies

This NIH (NCI) K99/R00 is a career-transition award for early-stage postdoctoral cancer researchers moving toward independent faculty positions; in this version the candidate may not lead an independent clinical trial (companion NOFOs cover those who will). It is applied for through a host institution such as a university, so eligibility centers on higher-education and research institutions rather than individuals on their own. Foreign institutions and the foreign components of U.S. organizations are not eligible to apply, though some foreign components are allowed. No award ceiling is stated in this record.

National Institutes of Health · Amount varies

This NIH K99/R00 award funds early-stage postdoctoral researchers transitioning to independent, tenure-track faculty positions, with an emphasis on cancer control, prevention, and data science. This specific NOFO is for those planning to lead an independent clinical trial as part of their career development; non-clinical-trial applicants must use a separate companion NOFO. It's aimed at eligible U.S. institutions, and the deadline is October 14, 2026.

National Institutes of Health · Amount varies

This NIH X01 opportunity provides access to biospecimens (urine, plasma, serum, genomic DNA) and related data from the Population Assessment of Tobacco and Health (PATH) Study rather than direct research funding. It is aimed at investigators at universities, research institutions, and similar eligible organizations, including various minority-serving institutions and tribal entities. Foreign (non-U.S.) organizations and foreign components are not eligible. No award amounts are listed; this is a resource-access mechanism for researchers, not a general grant for nonprofits, businesses, or individuals.

National Institutes of Health · Amount varies

This NIH R01 grant supports development of novel theory and methods to understand how genetic and non-genetic factors shape complex human traits, using interdisciplinary modeling and large-scale datasets. It is a research grant aimed primarily at universities, research institutions, and similar eligible organizations, including various minority-serving institutions, tribal entities, and foreign organizations. No award amounts are specified. Clinical trials are not allowed under this opportunity, and the eligibility list is research-institution oriented rather than open to nonprofits, small businesses, or individuals broadly.

National Institutes of Health · Up to $350K

This NIH/NCI R01 grant funds secondary analysis and integration of existing datasets to study cancer risk and related outcomes such as survival and treatment response. It is a research grant for universities, research institutions, and similar eligible organizations, including various minority-serving institutions, tribal entities, and foreign organizations. The award maximum is about $350,000. Eligibility is oriented toward research institutions rather than nonprofits, small businesses, or individuals broadly, and applicants typically need access to relevant existing data.

National Institutes of Health · Up to $750K

NIH (NIDA) K12 institutional career-development funding to support mentored research training for clinician-scientists in substance use and substance use disorder research. Intended for institutions that will run a scholar training program; foreign organizations are not eligible and foreign components are not allowed. The listed maximum is about $750,000. This is an institutional training award, not a grant for individuals or general nonprofits.

National Institutes of Health · Up to $50K

This NIH grant (up to $50,000) funds small research projects studying the ethical, legal, and social implications (ELSI) of human genetics and genomics, including single-investigator studies, preliminary data collection, and secondary data analysis. It's aimed at eligible U.S. and territorial research institutions. The deadline is November 16, 2026.